Valuation: Divi's Laboratories Limited

Market Cap 2,968B 32.05B 29.19B 26.9B 24.47B 45.91B 48.25B 327B 130B 1,621B 120B 118B 5,088B P/E 2027 *
75.1x
P/E 2028 * 65.5x
Enterprise Value 2,932B 31.66B 28.84B 26.57B 24.17B 45.34B 47.65B 323B 129B 1,601B 119B 116B 5,025B EV / Sales 2027 *
21.2x
EV / Sales 2028 * 17.8x
Free-Float
48%
Yield 2027 *
0.33%
Yield 2028 * 0.37%
1 day+0.02%
1 week-2.29%
Current month+14.32%
1 month+21.66%
3 months+30.05%
6 months+63.03%
Current year+74.90%
1 week 10,954
Extreme 10954
11,544.5
1 month 8,797
Extreme 8797
11,824
Current year 5,647.5
Extreme 5647.5
11,824
1 year 5,647.5
Extreme 5647.5
11,824
3 years 3,350
Extreme 3350
11,824
5 years 2,730
Extreme 2730
11,824
10 years 532.65
Extreme 532.65
11,824
Manager TitleAgeSince
Chief Executive Officer 75 25/11/2009
Chief Executive Officer 49 03/01/2020
Director of Finance/CFO 65 31/07/2025
Director TitleAgeSince
Director/Board Member 49 25/11/2009
Chairman 75 25/11/2009
Director/Board Member 68 01/10/1994
Date Insider Type Main position Quantity % Market Cap. Importance
26/03/25 Sell

Executive/Senior Manager

25,000 0.0094%
15/03/25 Sell 300 0.0001%
17/02/25 Sell 500 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
+0.02%-2.29%+75.44%+200.42% 32.05B
-0.30%-6.68%+27.12%+127.32% 1,200B
+1.25%-5.35%+32.65%+78.98% 651B
+0.94%-2.99%+21.13%+106.30% 506B
-0.60%-1.95%+25.73%+67.00% 377B
+0.69%-9.50%+36.78%+30.83% 330B
+0.41%-4.70%+24.18%+50.18% 288B
+0.81%-4.08%-2.95%+31.59% 272B
-0.15%-6.45%+29.06%+65.76% 236B
-0.06%-0.98%+31.42%+122.83% 206B
Average +0.30%-4.51%+30.06%+88.12% 410B
Weighted average by Cap. +0.30%-5.17%+26.41%+88.76%

Financials

2027 *2028 *
Net sales 138B 1.49B 1.36B 1.25B 1.14B 2.14B 2.25B 15.24B 6.06B 75.47B 5.6B 5.48B 237B 164B 1.77B 1.62B 1.49B 1.35B 2.54B 2.67B 18.13B 7.21B 89.77B 6.66B 6.52B 282B
Net income 39.52B 427M 389M 358M 326M 611M 642M 4.36B 1.73B 21.59B 1.6B 1.57B 67.74B 44.81B 484M 441M 406M 369M 693M 728M 4.94B 1.96B 24.48B 1.82B 1.78B 76.82B
Net Debt -36.38B -393M -358M -330M -300M -563M -591M -4.01B -1.6B -19.87B -1.47B -1.44B -62.37B -49.7B -537M -489M -450M -410M -769M -808M -5.48B -2.18B -27.14B -2.01B -1.97B -85.19B
Projected Income Statement - Annual - Divi's Laboratories Limited
Logo Divi's Laboratories Limited
Divi's Laboratories Limited is specialized in the development and manufacture of active pharmaceutical ingredients, intermediates and nutraceutical ingredients. Net sales by source of revenue break down into product sales (97.9%) and service sales (2.1%). At the end of March 2020, the group has 2 production sites located in India.
Employees
11,565
Date Price Change Volume
20/11/26 ₹11,180.50 +0.02% 404,825
19/11/26 ₹11,178.00 +1.17% 619,182
18/11/26 ₹11,049.00 -0.91% 472,914
17/11/26 ₹11,150.00 +0.63% 727,653
16/11/26 ₹11,080.00 -3.16% 903,749
Trader
Investor
Global
Quality
ESG MSCI
BB
MarketScreener Ratings - Divi's Laboratories Limited
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
11,180.50INR
Average target price
11,163.39INR
Spread / Average Target
-0.15%
  1. Stock Market
  2. Stocks
  3. DIVISLAB Stock